iCo Therapeutics (OTCMKTS:ICOTF) Share Price Passes Below Two Hundred Day Moving Average of $0.06

Share on StockTwits

iCo Therapeutics Inc (OTCMKTS:ICOTF)’s share price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.06 and traded as low as $0.11. iCo Therapeutics shares last traded at $0.11, with a volume of 5,000 shares trading hands.

The business’s 50-day simple moving average is $0.07 and its 200-day simple moving average is $0.06.

iCo Therapeutics Company Profile (OTCMKTS:ICOTF)

iCo Therapeutics Inc, a biotechnology company, focuses on the identification, development, and commercialization of drug candidates to treat sight and life threatening diseases. Its in-licensed product candidates include iCo-008, a human monoclonal antibody, which is in Phase II clinical trial to treat sight threatening ocular allergies and various systemic disease indications; and Oral AmpB Delivery System that is in pre-clinical stage used for the treatment of systemic fungal infections.

Read More: How to calculate compound interest

Receive News & Ratings for iCo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iCo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.